Preoperative timolol and ocular compression in cataract surgery.

Area of Science:

• Ophthalmology
• Surgical Innovation
• Pharmacology

Background:

• Preventing vitreous loss during cataract surgery is crucial for optimal patient outcomes.
• Digital ocular compression is a common method to reduce intraocular pressure (IOP) pre-operatively.
• Pharmacological agents are often used adjunctively to enhance IOP reduction.

Purpose of the Study:

• To compare the efficacy of topical timolol versus combined acetazolamide-mannitol pre-medication in reducing IOP during digital ocular compression for cataract surgery.
• To evaluate the impact of these pre-medications on preventing vitreous loss.

Main Methods:

• A comparative study involving two groups of patients undergoing cataract surgery.
• Group 1 received topical timolol with digital ocular compression.
• Group 2 received combined acetazolamide-mannitol pre-medication with digital ocular compression.

Main Results:

• Both interventions significantly reduced intraocular pressure (IOP).
• The acetazolamide-mannitol group achieved a greater reduction in IOP, resulting in deeper hypotony.
• No instances of vitreous loss were reported in either group.
• Post-operative healing was uncomplicated in all patients.

Conclusions:

• Both topical timolol and acetazolamide-mannitol are effective in reducing IOP for cataract surgery.
• Acetazolamide-mannitol offers a more profound IOP reduction, potentially due to mannitol's vitreous-reducing properties.
• Both methods contribute to preventing vitreous loss and ensuring uncomplicated healing.